Previous Article | Next Article ![]()
Journal of Clinical Microbiology, May 2001, p. 1922-1927, Vol. 39, No. 5
Unité de Virologie, Centre de
Recherches du Service de Santé des Armées (CRSSA) Emile
Pardé, Grenoble,1
Hôpital Pasteur, Colmar,2 and
Université Louis Pasteur,
Strasbourg,3 France
Received 14 August 2000/Returned for modification 29 December
2000/Accepted 1 March 2001
Arthropod-transmitted flaviviruses are responsible for considerable
morbidity and mortality, causing severe encephalitic, hemorrhagic, and
febrile illnesses in humans. Because there are no specific clinical
symptoms for infection by a determined virus and because different
arboviruses could be present in the same area, a genus diagnosis by PCR
would be a useful first-line diagnostic method. The six published
Flavivirus genus primer pairs localized in the NS1, NS3,
NS5, and 3' NC regions were evaluated in terms of specificity and
sensitivity with flaviviruses (including the main viruses pathogenic
for humans) at a titer of 105 50% tissue culture
infectious doses (TCID50s) ml
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.5.1922-1927.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Comparison of Flavivirus Universal Primer Pairs
and Development of a Rapid, Highly Sensitive Heminested Reverse
Transcription-PCR Assay for Detection of Flaviviruses Targeted to a
Conserved Region of the NS5 Gene Sequences
1 with a common
identification step by agarose gel electrophoresis. Only one NS5
primer pair allowed the detection of all tested flaviviruses with the
sensitivity limit of 105 TCID50s
ml
1. Using a heminested PCR with new primers designed in
the same region after an alignment of 30 different flaviviruses, the
sensitivity of reverse transcription-PCR was improved and allowed the
detection of about 200 infectious doses ml
1 with all of
the tick- and mosquito-borne flaviviruses tested. It was confirmed that
the sequenced amplified products in the NS5 region allowed
predictability of flavivirus species by dendrogram, including the New
York 99 West Nile strain. This technique was successfully performed
with a cerebrospinal fluid sample from a patient hospitalized with West
Nile virus encephalitis.
*
Corresponding author. Mailing address: CRSSA, 24 Avenue
des Maquis du Grésivaudan, BP87, 38702 La Tronche Cedex, France. Phone: 33-476-63-68-44. Fax: 33-476-63-69-17. E-mail:
Daniel.Garin{at}wanadoo.fr.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|